Episcleritis: Difference between revisions

(Text replacement - "Category:Ophtho" to "Category:Ophthalmology")
(Text replacement - "* " to "*")
Line 1: Line 1:
==Background==
==Background==
* Abrupt onset of inflammation in the episclera
*Abrupt onset of inflammation in the episclera
* 70% of cases occurs in women (usually young/middle-aged)
*70% of cases occurs in women (usually young/middle-aged)
* Usually a benign, self-limited condition
*Usually a benign, self-limited condition
* Can be classified into simple (more common) or nodular types
*Can be classified into simple (more common) or nodular types
* Most commonly idiopathic but may occur as an ocular manifestation of underlying autoimmune conditions eg RA, IBD
*Most commonly idiopathic but may occur as an ocular manifestation of underlying autoimmune conditions eg RA, IBD


==Clinical Features==
==Clinical Features==
[[File:Episcleritiseye.jpg|thumb|Episcleritis]]
[[File:Episcleritiseye.jpg|thumb|Episcleritis]]
===History===
===History===
* Abrupt onset of redness, irritation, and watering of the eye
*Abrupt onset of redness, irritation, and watering of the eye
* Pain is unusual
*Pain is unusual
* Vision unaffected
*Vision unaffected
* 50% of cases are bilateral
*50% of cases are bilateral


===Physical exam===
===Physical exam===
Line 23: Line 23:


==Diagnosis==
==Diagnosis==
* Must distinguish from [[scleritis]]
*Must distinguish from [[scleritis]]
**Scleritis likely to have pain and decreased vision  
**Scleritis likely to have pain and decreased vision  
**Use of 2.5% phenylephrine drops will cause vasoconstriction/blanching of episcleral but not scleral vessels. Thus, there will be decreased injection and redness in episcleritis but not scleritis.<ref>Mahmood AR, Narang AT. Diagnosis and management of the acute red eye. Emerg Med Clin North Am 2008; 26:35-55.</ref>
**Use of 2.5% phenylephrine drops will cause vasoconstriction/blanching of episcleral but not scleral vessels. Thus, there will be decreased injection and redness in episcleritis but not scleritis.<ref>Mahmood AR, Narang AT. Diagnosis and management of the acute red eye. Emerg Med Clin North Am 2008; 26:35-55.</ref>
**Red area will be mobile if moved with a moist q-tip
**Red area will be mobile if moved with a moist q-tip
* Must distinguish from [[conjunctivitis]]
*Must distinguish from [[conjunctivitis]]
**Episcleritis will usually have a sectoral pattern of injection, as opposed to a diffuse injection seen in conjunctivitis.
**Episcleritis will usually have a sectoral pattern of injection, as opposed to a diffuse injection seen in conjunctivitis.



Revision as of 21:17, 5 July 2016

Background

  • Abrupt onset of inflammation in the episclera
  • 70% of cases occurs in women (usually young/middle-aged)
  • Usually a benign, self-limited condition
  • Can be classified into simple (more common) or nodular types
  • Most commonly idiopathic but may occur as an ocular manifestation of underlying autoimmune conditions eg RA, IBD

Clinical Features

Episcleritis

History

  • Abrupt onset of redness, irritation, and watering of the eye
  • Pain is unusual
  • Vision unaffected
  • 50% of cases are bilateral

Physical exam

  • Vasodilatation of the superficial episcleral vessels
  • Focal area(s) of redness
  • May have a tender scleral nodule (nodular episcleritis)

Differential Diagnosis

Unilateral red eye

^Emergent diagnoses ^^Critical diagnoses

Diagnosis

  • Must distinguish from scleritis
    • Scleritis likely to have pain and decreased vision
    • Use of 2.5% phenylephrine drops will cause vasoconstriction/blanching of episcleral but not scleral vessels. Thus, there will be decreased injection and redness in episcleritis but not scleritis.[1]
    • Red area will be mobile if moved with a moist q-tip
  • Must distinguish from conjunctivitis
    • Episcleritis will usually have a sectoral pattern of injection, as opposed to a diffuse injection seen in conjunctivitis.

Management

  • Topical lubricants
    • Artificial tears q4-6hr
  • Oral NSAIDs

Disposition

  • Refer to ophtho is unsure of diagnosis or if steroids are necessary for Tx
  • Self-limiting (will resolve within 2-3 weeks)

See Also

External Links

References

  1. Mahmood AR, Narang AT. Diagnosis and management of the acute red eye. Emerg Med Clin North Am 2008; 26:35-55.